NEMUS Bioscience, Inc.

NEMUS Bioscience Inc. is a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids.

SEC Filings

2017 2016 2015 2014 2013 2012 2011

Date Filing Description Download

08-11-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)

08-11-2017 10-Q Quarterly Report

07-11-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)

07-11-2017 8-K Current report filing

05-12-2017 10-Q Quarterly Report

05-12-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)

05-04-2017 8-K Current report filing

03-28-2017 SC 13D/A Amended Statement of Beneficial Ownership

03-28-2017 4 Statement of Changes in Beneficial Ownership

03-23-2017 EFFECT Effectiveness Order

03-23-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)

03-13-2017 S-1 Securities Registration Statement

03-10-2017 10-K Annual Report

02-08-2017 EFFECT Effectiveness Order

02-08-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)

02-06-2017 CT ORDER Confidential Treatment Order

01-20-2017 S-1 Securities Registration Statement

01-20-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)

01-20-2017 8-K/A Amended Current report filing

01-13-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)

01-13-2017 8-K Current report filing

01-13-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)

01-13-2017 D Small Company Offering and Sale of Securities Without Registration

01-11-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)

01-10-2017 8-K Current report filing

NEMUS Bioscience, Inc.

SEC Filings

Site Map

Corporate Governance